InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Explore the detailed record of transactions filed by SIMARD JOHN, Chairman & CEO. Officer active across 1 companies, notably XBiotech Inc.. Aggregated, 13 disclosures have been recorded. Total volume traded: €3.9m. The latest transaction was disclosed on 15 October 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
€195,37617,000 shares@ €11.49270.26% mcap5.1% of flow
Common Stock
SEC:0001209191-22-009745:0·
€423,11539,286 shares@ €10.770123.1% of flow
Common Stock
SEC:0001209191-21-060523·
€423,11539,286 shares@ €10.77010.56% mcap11.0% of flow
Common Stock
SEC:0001209191-21-060523:0·
€266,70023,681 shares@ €11.262214.6% of flow
Common Stock
SEC:0001209191-21-059849·
€266,70023,681 shares@ €11.26220.36% mcap6.9% of flow
Common Stock
SEC:0001209191-21-059849:0·
€76,4686,263 shares@ €12.20964.2% of flow
Common Stock
SEC:0001209191-21-058475·
€76,4686,263 shares@ €12.20960.10% mcap2.0% of flow
Common Stock
SEC:0001209191-21-058475:0·
€123,6949,892 shares@ €12.50446.8% of flow
Common Stock
SEC:0001209191-21-057877·
€123,6949,892 shares@ €12.50440.16% mcap3.2% of flow
Common Stock
SEC:0001209191-21-057877:0·
€172,98413,471 shares@ €12.84129.5% of flow
Common Stock
SEC:0001209191-21-057295·
€172,98413,471 shares@ €12.84120.23% mcap4.5% of flow
Common Stock
SEC:0001209191-21-057295:0·
€766,77450,000 shares@ €15.335541.9% of flow
Common Stock
SEC:0001209191-21-047105·
€766,77450,000 shares@ €15.33551.02% mcap19.9% of flow
Common Stock
SEC:0001209191-21-047105:0·
13 of 13 declarations
About SIMARD JOHN
John Simard is Chief Executive Officer of XBiotech Inc. In this role, he oversees the company's operations and defines its overall strategy. Simard plays a key role in developing new treatments and innovation in the biotechnology field. His leadership is crucial for the growth of XBiotech.
